Quantification of radiation-induced lung damage with CT scans: The possible benefit for radiogenomics

Acta Oncologica

Volumn 52, Issue 7, 2013, Pages 1405-1410

  De Ruysscher, Dirk ^a   Sharifi, Hoda ^a   Defraene, Gilles ^a   Kerns, Sarah L ^b,c   Christiaens, Melissa ^a   De Ruyck, Kim ^d   Peeters, Stéphanie ^a   Vansteenkiste, Johan ^a   Jeraj, Robert ^e   Van Den Heuvel, Frank ^a   Van Elmpt, Wouter ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d GHENT UNIVERSITY   (Belgium)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; GEMCITABINE; NAVELBINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DOSIMETRY; DYSPNEA; FEMALE; GENOMICS; HOUNSFIELD UNIT; HUMAN; IMAGE ANALYSIS; LUNG INJURY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INDUCED LUNG DAMAGE; RADIATION INJURY; RADIOGENOMICS; RADIOLOGICAL PARAMETERS; RADIOSENSITIVITY; STEREOTACTIC RADIOTHERAPY; CLINICAL PRACTICE; EXPIRATORY RESERVE VOLUME; NON SMALL CELL LUNG CANCER; RETROSPECTIVE STUDY; SMALL CELL LUNG CANCER; STEREOTACTIC TREATMENT; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DYSPNEA; FEMALE; GENOMICS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; RADIOGRAPHY, THORACIC; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884545769     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.813074     Document Type: Article

References (28)

1. Dehing-Oberije C, De Ruysscher D, van Baardwijk A, Yu S, Rao B, Lambin P. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiother Oncol 2009;91:421-6
2. Vogelius IR, Bentzen SM. Aliterature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol 2012;51:975-83
3. Huang EX, Hope A J, Lindsay PE, Trovo M, El Naqa I, Deasy JO, et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011;50:51-60
4. Ghobadi G, Van Der Veen S, Bartelds B, De Boer RA, Dickinson MG, de Jong JR, et al. PhysiologicaLinteraction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys 2012;84:e639-46
5. Pang Q, Wei Q, Xu T, Yuan X, Lopez Guerra JL, Levy LB, et al. Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2013;85:1332-9
6. Xiong H, Liao Z, Liu Z, Xu T, Wang Q, Liu H, et al. A TM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with defi nitive radiation therapy. Int J Radiat Oncol Biol Phys 2013;85:1066-73
7. Yin M, Liao Z, Liu Z, Wang LE, O ' Reilly M, Gomez D, et al. Genetic variants of the nonhomologous end joining genElIG4 and severe radiation pneumonitis in non-small cell lung cancer patients treated with defi nitive radiotherapy. Cancer 2012;118:528-35
8. Yin M, Liao Z, Liu Z, Wang LE, Gomez D, Komaki R, et al. Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with defi nitive radiation therapy. Int J Radiat Oncol Biol Phys 2011;81:e67-73
9. Hildebrandt M A, Komaki R, Liao Z, Gu J, Chang J Y, Ye Y, et al. Genetic variants in infl ammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 2010;5:e12402
10. Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, Mao L, et al. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with defi nitive radiotherapy. J Clin Oncol 2009;27:3370-8
11. Barnett GC, Elliott RM, Alsner J, Andreassen CN, Abdelhay O, Burnet NG, et al. Individual patient data metaanalysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. Radiother Oncol 2012;105:289-95
12. Talbot C J, Tanteles G A, Barnett G C, Burnet NG, Chang-Claude J, Coles CE, et al. A replicated association between polymorphisms near TNF 〈 and risk for adverse reactions to radiotherapy. Br J Cancer 2012;107:748-53
13. Barnett GC, Coles CE, Elliott RM, Baynes C, Luccarini C, Conroy D, et al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: A prospective analysis study. Lancet Oncol 2012;13:65-77
14. West CM, Barnett GC. G enetics and genomics of radiotherapy toxicity: Towards prediction. Genome Med 2011;3:52
15. Voets AM, Oberije C, Struijk RB, Reymen B, De Ruyck K, Thierens H, et al. No association between TGF-® 1 polymorphisms and radiation-induced lung toxicity in a European cohort of lung cancer patients. Radiother Oncol 2012;105:296-8
16. Lopez Guerra JL, Gomez D, Zhuang Y, Levy LB, Eapen G, Liu H, et al. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012;83:1573-9
17. Tucker SL, Jin H, Wei X, Wang S, Martel MK, Komaki R, et al. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in Alarge cohort of patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2010;77:691-8
18. Yirmibesoglu E, Higginson D S, Fayda M, Rivera MP, Halle J, Rosenman J, et al. Challenges scoring radiation pneumonitis in patients irradiated for lung cancer. Lung Cancer 2012;76:350-3
19. Ghobadi G, Hogeweg LE, Faber H, Tukker WG, Schippers JM, Brandenburg S, et al. Quantifying local radiation-induced lung damage from computed tomography. Int J Radiat Oncol Biol Phys 2010;76:548-56
20. Diot Q, Kavanagh B, Schefter T, Gaspar L, Stuhr K, Miften M. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors. Int J Radiat Oncol Biol Phys 2012;84:1024-30
21. De Ruysscher D, Faivre-Finn C, Nestle U, Hurkmans C W, Le Péchoux C, Price A, et al. European Organisation for ResearcHand Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radio therapy for lung cancer. J Clin Oncol 2010;28:5301-10
22. Janssens G, Jacques L, Orban de Xivry J, Geets X, Macq B. Diffeomorphic registration of images with variable contrast enhancement. Int J BiomeDimaging 2011;2011:891585
23. Sarrut D, Boldea V, Miguet S, Ginestet C. Simulation of four-dimensional CT images from deformable registration between inhale anDexhale breath-hold CT scans. Med Phys 2006;33:605-17
24. Bakker ME, Stolk J, Putter H, Shaker S B, Parr D G, Piitulainen E, et al. Variability in densitometric assessment of pulmonarYemphysema with computed tomography. Invest Radiol 2005;40:777-83
25. Palma DA, van S ör nsen de Koste JR, Verbakel WF, Senan S. A new approach to quantifying lung damage after stereotactic body radiation therapy. Acta Oncol 2011;50:509-17
26. Partridge M, Yamamoto T, Grau C, Høyer M, Muren L P. Imaging of normal lung, liver and parotid gland function for radiotherapy. Acta Oncol 2010;49:997-1011
27. Nyeng TB, Kallehauge J F, Høyer M, Petersen J B, Poulsen PR, Muren LP. Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients. Acta Oncol 2011;50:897-907
28. Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward A D. Distinguishing radiation fi brosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: A quantitative analysis of CT density changes. Acta Oncol 2013;52:910-8